Supply report · August 2026 register copy
Eye & Ear Drops in Nigeria: the registration data
Across the 3 eye and ear drop molecules Ogbogwu tracks, our August 2026 copy of the NAFDAC Greenbook lists 93 active registrations held by 62 companies — plus 73 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.
- Active registrations
- 93
- Companies
- 62
- New in the last 12 months
- 9
- Renewals due within a year
- 24
Who holds the registrations
The ten companies with the most active eye and ear drop registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.
- 1.Maydon Pharmaceuticals— 5 active
- 2.Pharmacy Plus— 5 active
- 3.Lin-Kabs Pharmaceutical— 4 active
- 4.Fidson Healthcare— 3 active
- 5.Krishat Pharma Industries— 3 active
- 6.Mankind Life-Sciences— 3 active
- 7.Aphantee Pharma Nigeria— 2 active
- 8.BUCHCOLL PHARMACEUTICALS— 2 active
- 9.Chevnor Pharmaceutical— 2 active
- 10.City of Glory— 2 active
Where the products are made
Maker country as the register records it, across the 93 active registrations.
- India— 66 (71%)
- Nigeria— 9 (10%)
- China— 5 (5%)
- Macao— 3 (3%)
- Bangladesh— 2 (2%)
- Belgium— 1 (1%)
- Egypt— 1 (1%)
- France— 1 (1%)
Dosage forms
- Tablet— 50 active
- Eye drops— 20 active
- Solution/Drops— 8 active
- Capsule— 5 active
- Ear/eye drops— 4 active
- Drops— 1 active
- Ear drops— 1 active
- Eye ointment— 1 active
Newest registrations
The latest eye and ear drop approvals in our copy — 9 products were registered in the twelve months to August 2026.
24 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order. See which ones, by month →
The molecules behind these numbers
- Ofloxacin (eye & ear drops) — 50 active registrations
- Timolol (glaucoma eye drops) — 14 active registrations
- Chloramphenicol (eye & ear drops) — 10 active registrations
“Eye & Ear Drops” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.
The most-supplied presentations
- Ofloxacin (eye & ear drops) 400 mg tablet — 22 companies
- Ofloxacin (eye & ear drops) 200 mg tablet — 19 companies
- Timolol (glaucoma eye drops) 0.5% eye drops — 7 companies
- Chloramphenicol (eye & ear drops) 250 mg capsule — 4 companies
- Ofloxacin (eye & ear drops) 0.3% ear/eye drops — 4 companies
Manufacturing or exporting eye and ear drop medicines?
This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.
Supply the Nigerian marketOther supply reports
This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.